SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001842952-21-000009
Filing Date
2021-11-01
Accepted
2021-11-01 16:31:17
Documents
1
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163579861906118.html 4  
1 FORM 4 wf-form4_163579861906118.xml 4 3837
  Complete submission text file 0001842952-21-000009.txt   5334
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 MILLER AVENUE SUITE 100 ANN ARBOR MI 48104
Business Address
Minai-Azary Jennifer Lynn (Reporting) CIK: 0001844398 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 211367654